FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009676026> ?p ?o ?g. }

• W2009676026 endingPage "1232" @default.
• W2009676026 startingPage "1225" @default.
• W2009676026 abstract "Rationale and Objectives To define the best independent predictors for active inflammation in patients with Crohn disease (CD) examined by contrast-enhanced magnetic resonance (MR) enterography. Materials and Methods Ninety-one patients (47 men and 44 women; aged 39.58 ± 17.1 years) with a diagnosis of CD; CD activity index (CDAI) ≥150 (n = 19 patients) or <150 (n = 72) underwent MR enterography including T2-weighted half-Fourier acquisition single-shot turbo spin-echo, T2-weighted spectral fat presaturation with inversion recovery, T1-weighted balanced steady-state free precession, and T1-weighted breath-hold resolution isotropic high volume three-dimensional MR imaging sequences before and after administration of gadobenate dimeglumine during arterial (30 seconds), portal venous (70 seconds), and delayed phase (3 and 5 minutes from contrast injection). Two readers analyzed the MR images in consensus. Reference standard was the Crohn's Disease Endoscopic Index of Severity (CDEIS) with deep mucosal biopsy or the histologic analysis of the surgical specimen in those patients (n = 30) who underwent elective small-bowel resection. Univariate and multivariate logistic regression analyses were performed to assess CDAI, biochemical markers (C-reactive protein and fecal calprotectin levels) and MR imaging findings as potential predictors of inflammatory CD activity. Results Patients revealed prevalently active (n = 47 patients) or quiescent CD with mural fibrosis (n = 44 patients). The bowel wall T2 hyperintensity (odds ratio [OR], 9.20; 95% confidence interval [CI], 2.71–31.19) and total length of disease (OR, 1.29; 95% CI, 1.11–1.49) were found as the best independent predictors of active CD. CDAI, C-reactive protein, and fecal calprotectin were not found independent predictors of active CD. Conclusions The bowel wall T2 hyperintensity and the length of the involved bowel tract were predictors of active inflammation in patients with CD examined by contrast-enhanced MR enterography. To define the best independent predictors for active inflammation in patients with Crohn disease (CD) examined by contrast-enhanced magnetic resonance (MR) enterography. Ninety-one patients (47 men and 44 women; aged 39.58 ± 17.1 years) with a diagnosis of CD; CD activity index (CDAI) ≥150 (n = 19 patients) or <150 (n = 72) underwent MR enterography including T2-weighted half-Fourier acquisition single-shot turbo spin-echo, T2-weighted spectral fat presaturation with inversion recovery, T1-weighted balanced steady-state free precession, and T1-weighted breath-hold resolution isotropic high volume three-dimensional MR imaging sequences before and after administration of gadobenate dimeglumine during arterial (30 seconds), portal venous (70 seconds), and delayed phase (3 and 5 minutes from contrast injection). Two readers analyzed the MR images in consensus. Reference standard was the Crohn's Disease Endoscopic Index of Severity (CDEIS) with deep mucosal biopsy or the histologic analysis of the surgical specimen in those patients (n = 30) who underwent elective small-bowel resection. Univariate and multivariate logistic regression analyses were performed to assess CDAI, biochemical markers (C-reactive protein and fecal calprotectin levels) and MR imaging findings as potential predictors of inflammatory CD activity. Patients revealed prevalently active (n = 47 patients) or quiescent CD with mural fibrosis (n = 44 patients). The bowel wall T2 hyperintensity (odds ratio [OR], 9.20; 95% confidence interval [CI], 2.71–31.19) and total length of disease (OR, 1.29; 95% CI, 1.11–1.49) were found as the best independent predictors of active CD. CDAI, C-reactive protein, and fecal calprotectin were not found independent predictors of active CD. The bowel wall T2 hyperintensity and the length of the involved bowel tract were predictors of active inflammation in patients with CD examined by contrast-enhanced MR enterography." @default.
• W2009676026 created "2016-06-24" @default.
• W2009676026 creator A5003636856 @default.
• W2009676026 creator A5032599288 @default.
• W2009676026 creator A5042099303 @default.
• W2009676026 creator A5047672248 @default.
• W2009676026 creator A5052904184 @default.
• W2009676026 creator A5063760648 @default.
• W2009676026 creator A5068722269 @default.
• W2009676026 date "2014-10-01" @default.
• W2009676026 modified "2023-10-03" @default.
• W2009676026 title "Biochemical Markers and MR Imaging Findings as Predictors of Crohn Disease Activity in Patients Scanned by Contrast-enhanced MR Enterography" @default.
• W2009676026 cites W1968366145 @default.
• W2009676026 cites W1998562401 @default.
• W2009676026 cites W2022352395 @default.
• W2009676026 cites W2029746055 @default.
• W2009676026 cites W2045601226 @default.
• W2009676026 cites W2049596761 @default.
• W2009676026 cites W2053155919 @default.
• W2009676026 cites W2054755479 @default.
• W2009676026 cites W2055567006 @default.
• W2009676026 cites W2055833760 @default.
• W2009676026 cites W2060308357 @default.
• W2009676026 cites W2066740290 @default.
• W2009676026 cites W2068172595 @default.
• W2009676026 cites W2074100287 @default.
• W2009676026 cites W2079706496 @default.
• W2009676026 cites W2091608186 @default.
• W2009676026 cites W2099131015 @default.
• W2009676026 cites W2107944035 @default.
• W2009676026 cites W2114009152 @default.
• W2009676026 cites W2126261425 @default.
• W2009676026 cites W2129175768 @default.
• W2009676026 cites W2132207481 @default.
• W2009676026 cites W2147015319 @default.
• W2009676026 cites W2162756313 @default.
• W2009676026 cites W2164970509 @default.
• W2009676026 cites W2166130512 @default.
• W2009676026 cites W2171484002 @default.
• W2009676026 cites W2314847792 @default.
• W2009676026 cites W4247247504 @default.
• W2009676026 cites W4382448965 @default.
• W2009676026 doi "https://doi.org/10.1016/j.acra.2014.05.002" @default.
• W2009676026 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24998692" @default.
• W2009676026 hasPublicationYear "2014" @default.
• W2009676026 type Work @default.
• W2009676026 sameAs 2009676026 @default.
• W2009676026 citedByCount "10" @default.
• W2009676026 countsByYear W20096760262014 @default.
• W2009676026 countsByYear W20096760262016 @default.
• W2009676026 countsByYear W20096760262017 @default.
• W2009676026 countsByYear W20096760262019 @default.
• W2009676026 countsByYear W20096760262020 @default.
• W2009676026 countsByYear W20096760262021 @default.
• W2009676026 crossrefType "journal-article" @default.
• W2009676026 hasAuthorship W2009676026A5003636856 @default.
• W2009676026 hasAuthorship W2009676026A5032599288 @default.
• W2009676026 hasAuthorship W2009676026A5042099303 @default.
• W2009676026 hasAuthorship W2009676026A5047672248 @default.
• W2009676026 hasAuthorship W2009676026A5052904184 @default.
• W2009676026 hasAuthorship W2009676026A5063760648 @default.
• W2009676026 hasAuthorship W2009676026A5068722269 @default.
• W2009676026 hasConcept C126322002 @default.
• W2009676026 hasConcept C126838900 @default.
• W2009676026 hasConcept C143409427 @default.
• W2009676026 hasConcept C144301174 @default.
• W2009676026 hasConcept C156957248 @default.
• W2009676026 hasConcept C2779134260 @default.
• W2009676026 hasConcept C2779280984 @default.
• W2009676026 hasConcept C2989005 @default.
• W2009676026 hasConcept C38180746 @default.
• W2009676026 hasConcept C44249647 @default.
• W2009676026 hasConcept C71924100 @default.
• W2009676026 hasConcept C90924648 @default.
• W2009676026 hasConceptScore W2009676026C126322002 @default.
• W2009676026 hasConceptScore W2009676026C126838900 @default.
• W2009676026 hasConceptScore W2009676026C143409427 @default.
• W2009676026 hasConceptScore W2009676026C144301174 @default.
• W2009676026 hasConceptScore W2009676026C156957248 @default.
• W2009676026 hasConceptScore W2009676026C2779134260 @default.
• W2009676026 hasConceptScore W2009676026C2779280984 @default.
• W2009676026 hasConceptScore W2009676026C2989005 @default.
• W2009676026 hasConceptScore W2009676026C38180746 @default.
• W2009676026 hasConceptScore W2009676026C44249647 @default.
• W2009676026 hasConceptScore W2009676026C71924100 @default.
• W2009676026 hasConceptScore W2009676026C90924648 @default.
• W2009676026 hasIssue "10" @default.
• W2009676026 hasLocation W20096760261 @default.
• W2009676026 hasLocation W20096760262 @default.
• W2009676026 hasOpenAccess W2009676026 @default.
• W2009676026 hasPrimaryLocation W20096760261 @default.
• W2009676026 hasRelatedWork W1547383859 @default.
• W2009676026 hasRelatedWork W2016250642 @default.
• W2009676026 hasRelatedWork W2051499278 @default.
• W2009676026 hasRelatedWork W2119000026 @default.
• W2009676026 hasRelatedWork W2413002043 @default.
• W2009676026 hasRelatedWork W2767445481 @default.
• W2009676026 hasRelatedWork W2803332732 @default.

• next